Global Implantable Cardioverter Defibrillators (ICD) Market - Strategic Insights and Forecasts (2026-2031)

The global Implantable Cardioverter Defibrillators (ICD) market is projected to reach USD 7.20 billion by 2031, growing at a CAGR of 5.8% from USD 5.42 billion in 2026.

Major growth drivers include rising prevalence of sudden cardiac arrest, increasing heart failure cases, technological advancements in cardiac rhythm management, and expansion of electrophysiology procedures worldwide.

Key challenges include high device and implantation costs, surgical risks, device-related complications, and limited electrophysiology infrastructure in some developing regions.

North America leads the market due to advanced electrophysiology infrastructure, strong reimbursement systems, and high adoption of innovative cardiac rhythm technologies.

Cloud-based monitoring platforms, telemedicine integration, wireless connectivity, and remote electrophysiology management systems are improving long-term patient outcomes and healthcare efficiency.